Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06989593 · ClinicalTrials.gov registry record · NA
Breaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions
A NA study of Hypospadias and DSD, sponsored by Sarah Schlegel.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06989593 is a NA study of Hypospadias and DSD that is actively recruiting participants, run by Sarah Schlegel. The registered enrollment target is 20 participants, below the 146-participant average among 3 other Hypospadias trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06989593, a NA study of Hypospadias and DSD, is actively recruiting participants, sponsored by Sarah Schlegel.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn whether a journaling intervention can reduce stress and anxiety in parents of children with urogenital conditions (such as differences of sex development and hypospadias). The main questions it aims to answer are: * Does guided journaling help to reduce anxiety levels in parents of children with urogenital conditions? * What are parents' perspectives on group-based writing interventions for future support programs? Participants will: * Complete a short anxiety questionnaire (the General Anxiety Disorder-7 scale) at the beginning of the study * Receive a physical journal with 5 writing prompts designed to help process emotions related to their child's condition * Complete 5 journal entries over several weeks, writing about their experiences and feelings * Complete the same anxiety questionnaire again after finishing the journal entries * Participate in a 45-minute interview to discuss how the journaling affected their stress levels and gather feedback on potential group-based writing programs
Conditions Studied
Interventions
- BEHAVIORAL Narrative Medicine Journaling Intervention
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-10-10 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06989593
The ClinicalTrials.gov registry entry for NCT06989593 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 146-participant average among 3 other Hypospadias trials with a reported enrollment target (86% lower). The listed sponsor is Sarah Schlegel, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypospadias appearing as the primary indexed condition, and to 1 intervention - of which Narrative Medicine Journaling Intervention is the first listed.
NCT06989593 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06989593 about?
NCT06989593 is a clinical study titled "Breaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions". The goal of this clinical trial is to learn whether a journaling intervention can reduce stress and anxiety in parents of children with urogenital conditions (such as differences of sex development and hypospadias). The main questions it aims to answer are: * Does guided journaling help to reduce ...
What is the current status of trial NCT06989593?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-10-10. Estimated completion is 2026-05.
What conditions does trial NCT06989593 study?
This clinical trial studies the following conditions: Hypospadias, DSD.
What interventions are being tested in trial NCT06989593?
The interventions under investigation include: Narrative Medicine Journaling Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06989593?
This trial is sponsored by Sarah Schlegel, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06989593 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypospadias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.